Table: Phoenixbio -Q1 group results

PhoenixBio

13/08/2021 07:30

Aug 13 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2021        Jun 30, 2020     Mar 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              452 mln             162 mln           1.60     
                                       (-43.8 pct)                  
  Operating          69 mln           loss 133 mln        92 mln    
  Recurring          73 mln           loss 121 mln        91 mln    
  Net                64 mln           loss 121 mln        82 mln    
  EPS               19.69 yen        loss 39.64 yen      25.01 yen  
  EPS Diluted       12.91 yen                                       
  Ann Div                                  NIL              NIL     
  -Q2 div                                  NIL              NIL     
  -Q4 div                                  NIL              NIL     
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T